Revolution Medicines shared on LinkedIn:
“This summer, interns across Revolution Medicines are bringing fresh perspectives to projects that support our mission to outsmart RAS-addicted cancers.
As they learn alongside teams across the company, they’re getting a closer look at the science behind RevMed’s work and the patient impact that drives it forward.
We’re grateful for the energy they are bringing to RevMed, and we’re excited to spotlight their experiences this summer.”
Other articles about Revolution Medicines on OncoDaily.
